Oncodesign Precision Medicine Société anonyme Reports First Half 2025 Earnings

Advertisement

Oncodesign Precision Medicine Société anonyme (EPA:ALOPM) First Half 2025 Results

Key Financial Results

  • Net income: €9.85m (up from €3.60m loss in 1H 2024).
earnings-and-revenue-history
ENXTPA:ALOPM Earnings and Revenue History August 4th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Oncodesign Precision Medicine Société anonyme Earnings Insights

Looking ahead, revenue is expected to decline by 15% p.a. on average during the next 3 years, while revenues in the Biotechs industry in France are expected to grow by 21%.

Performance of the French Biotechs industry.

The company's shares are down 21% from a week ago.

Risk Analysis

You should learn about the 5 warning signs we've spotted with Oncodesign Precision Medicine Société anonyme (including 2 which are a bit unpleasant).

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About ENXTPA:ALOPM

Oncodesign Precision Medicine Société anonyme

A biopharmaceutical company, engages in the precision medicine business.

Undervalued with high growth potential.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0776.1% undervalued
208 users have followed this narrative
1 users have commented on this narrative
29 users have liked this narrative
SI
SimpleMan887
GME logo
SimpleMan887 on GameStop ·

GameStop will ace the financial crisis wave with its strategic Bitcoin investment and cash reserves

Fair Value:US$22089.6% undervalued
53 users have followed this narrative
2 users have commented on this narrative
21 users have liked this narrative
YI
HSAI logo
yiannisz on Hesai Group ·

The First Real Lidar Winner

Fair Value:US$27.0719.6% undervalued
13 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
TR
tripledub
TSM logo
tripledub on Taiwan Semiconductor Manufacturing ·

The Most Wonderful Monopoly in the Most Dangerous Neighbourhood on Earth

Fair Value:US$3814.1% undervalued
10 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

LO
Lou_Basenese
GIFT logo
Lou_Basenese on Giftify ·

Giftify ($GIFT): A Small-Cap Incentives Platform with More ScaleThan Its Valuation Suggests

Fair Value:US$2.558.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
3696 logo
AstrisCorporateAdvisory on Ceres ·

Proven business incubator in transition

Fair Value:JP¥2.37k36.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
FA
HEKTAR logo
FA_Trader on Hektar Real Estate Investment Trust ·

Hektar REIT: Outlook is getting more interesting as retail stabilises and diversification starts to kick in

Fair Value:RM 0.4910.2% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3955.5% undervalued
43 users have followed this narrative
3 users have commented on this narrative
41 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.1k% overvalued
36 users have followed this narrative
11 users have commented on this narrative
31 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3136.5% undervalued
1346 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

PI
GSVR logo
Piotr84 on Guanajuato Silver ·

Thank you. I was adding last 2 weeks as well.

1
|
0
DA
Dark_Oli
GSVR logo
Dark_Oli on Guanajuato Silver ·

Based on what ? the price you mark is speculative

0
|
0